Daily non-political popular news in brief.
Is the treatment of Parkinson's disease possible with a new neurotrophic factor in the future?
07-04-2007 · EurekAlert!The research group led by Mart Saarma, Director of the Institute of Biotechnology, University of Helsinki, has discovered a novel neurotrophic factor CDNF (Conserved Dopamine Neurotrophic Factor). CDNF was shown to protect and even rescue damaged dopamine neurons in an experimental model of Parkinson's disease in studies performed by the research group of professor Raimo K. Tuominen, faculty of pharmacy, University of Helsinki. More importantly, also the function of the neurons was recovered after an experimental lesion of the dopamine neurons in Substantia Nigra.
Read more »
Keywords: treatment, parkinson, disease, possible, neurotrophic, factor, future
« Previous | Next »
Similar news on "Is the treatment of Parkinson's disease possible with a new neurotrophic factor in the future?":
- Health care system for aging nerve cells
03-13-2007 · EurekAlert!
Uncontrolled neuronal death in the brain often gives rise to neurodegenerative illnesses like Parkinson or Alzheimer disease. Whether or not neurons have a long and healthy life is, apart from other factors, determined by the presence of neurotrophic factors. Scientists of the Max Planck Institute of Neurobiology have now provided unambiguous proof that the presence of the neurotrophic factor GDNF and its receptor Ret are essential for the survival of neurons in a specific brain region.
Similar news · Read more »
- Research shows new therapy is effective for patients with Crohn's disease
07-18-2007 · EurekAlert!
Mayo Clinic researchers have found that Certolizumab pegol is an effective treatment for adults with Crohn's disease, according to two new studies. These findings were published in today's issue of the New England Journal of Medicine. Certolizumab pegol blocks tumor necrosis factor, an important cause of inflammation in Crohn's disease
Similar news · Read more »
- The birth and death of dopamine neurons: A new model for neurodegeneration
12-10-2007 · EurekAlert!
The connection between development and neurodegeneration is emphasized via a new mouse knockout of a transcription factor that is critical for dopamine neuron specification, which produces a late-onset, asymmetric degenerative condition in a manner very similar to human Parkinson's disease.
Similar news · Read more »
- UAB research could improve the prognosis and treatment of lung cancer
01-07-2008 · EurekAlert!
A group of scientists at the Universitat Autтnoma de Barcelona, has published research on an enzyme that is detected in large quantities only in lung cancers. This enzyme can appear even when the cancer has not yet developed. Thus this molecule would serve as a good marker in the diagnosis and prognosis of the disease. The research is of great interest for potential future therapeutical applications as well.
Similar news · Read more »
- Model found to determine cause, possible treatment of nerve tumors
02-04-2008 · EurekAlert!
A multi-institutional study led by Cincinnati Children's Hospital Medical Center has led to new insights and a model to help unravel the cause of fibrous, noncancerous nerve tumors called neurofibromas, which can lead to disfigurement and in rare cases death by compressing vital organs. Writing for the February Cancer Cell, researchers said their findings also provide a way to test therapies that could eventually help patients with limited options for treating the disease -- Neurofibromatosis type 1.
Similar news · Read more »
- Program to freeze women's ovaries to preserve fertility after cancer
11-29-2006 · EurekAlert!
Northwestern University is launching an experimental program for young women who may be at risk to lose their ovarian function and fertility following treatment for cancer. In the program, a woman's ovary is removed and frozen for possible future use. The long-term goal is to be able to extract and mature eggs from cryopreserved (frozen) ovarian tissues to initiate pregnancies once cancer treatment has been completed. Thus far, pregnancies resulting from this research are in mice.
Similar news · Read more »
- Growth-factor antibody may treat chronic lung disease affecting premature infants
04-02-2007 · EurekAlert!
Researchers from Massachusetts General Hospital, in collaboration with scientists from the Genzyme Corporation, have identified a potential treatment for a chronic lung disease affecting premature infants. The scientists find that the activity of transforming growth factor-beta is elevated in the lungs of an animal model of bronchopulmonary dysplasia and that treatment with an antibody to TGF-beta decreased the growth factor’s activity and improved lung development.
Similar news · Read more »
- Study identifies novel Parkinson's disease drug target
06-21-2007 · EurekAlert!
Researchers at the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) have identified a potential new drug target for the treatment of Parkinson's disease and possibly for other degenerative neurological disorders.
Similar news · Read more »
- Predicting PET imaging's future: Diagnosing and treating diseases ASAP
11-01-2006 · EurekAlert!
Imagine a new world of detecting and diagnosing diseases sooner -- even before any symptoms are present. Consider the possibility of receiving individualized, targeted molecular, cellular or genetic medical treatment as soon as possible and of undergoing scanning that can quickly tell your doctor whether your treatment is working. Continued advances in positron emission tomography (PET) imaging are key to this future, according to Simon R. Cherry, professor of biomedical engineering at the University of California, Davis.
Similar news · Read more »
- Rush and UCSF found gene therapy appeared to reduce symptoms of Parkinson's by 40%
10-16-2006 · EurekAlert!
Ceregene, Inc., announced today that CERE-120, a gene therapy product in development for the treatment of Parkinson's disease, was well tolerated and appeared to reduce symptoms by approximately 40%.
Similar news · Read more »
